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Abstract
Detailed molecular analysis is of increasing importance in research into the regulation of biochemical pathways, organismal
growth and disease. Lipidomics in particular is increasingly sought after as it provides insight into molecular species involved in
energy storage, signalling and fundamental cellular structures. This has led to the use of a range of tools and techniques to acquire
lipidomics data. 31P NMR for lipidomics offers well-resolved head group/lipid class analysis, structural data that can be used to
inform and strengthen interpretation of mass spectrometry data and part of a priori structural determination. In the present study,
we codify the use of 31P NMR for lipidomics studies to make the technique more accessible to new users and more useful for a
wider range of questions. The technique can be used in isolation (phospholipidomics) or as a part of determining lipid compo-
sition (lipidomics). We describe the process from sample extraction to data processing and analysis. This pipeline is important
because it allows greater thoroughness in lipidomics studies and increases scope for answering scientific questions about lipid-
containing systems.
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Introduction
Lipidomics is of increasing importance in studies of living
systems as phospholipids, triglycerides and sterols have vari-
ous roles in metabolic disease, growth, infection and the struc-
ture of biological systems [1–12]. Lipidomics is complemen-
tary to approaches such as proteomics and transcriptomics,
and relatively quick to acquire and therefore cost effective.
Furthermore, an increasing array of techniques is becoming
available that make storing and extracting lipids from fibrous
and other sample types more efficient and consistent [13–15].
This makes lipidomics an increasingly attractive part of
hypothesis-driven research in biology.
The best strategy for acquiring lipidomics data from a large
number of samples in a single analytical batch is to use high-
throughput approaches such as high resolution mass spec-
trometry, typically Direct Infusion (DIMS) [16, 17]. This en-
ables large numbers of variables to be quantified in a large
number of samples relatively quickly, meaning the sample
numbers required for RCTs can be profiled in a single analyt-
ical batch. However, the lack of chromatography and the reli-
ance onm/z only for identification means that isobaric species
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are indistinguishable. This problem can be partially solved by
hyphenating liquid chromatography with MS (LCMS), which
can separate analytes chromatographically before detection.
Still, all MS based methodologies rely on the ionization effi-
ciency of lipids and although internal standards can be used to
correct for this, many aspects that influence ionization effi-
ciency and ion suppression are not comprehensively under-
stood. Therefore, neither DIMS nor LCMS is capable of of-
fering unambiguous structural data, meaning that MS can lack
specificity and clarity.
An orthogonal method of data acquisition can help to over-
come these fundamental limitations. An established technique
that is orthogonal to MS and useful for determining molecular
structure precisely is NMR. NMR is based on the molecular
environment of atomic nuclei with a spin of ½, with most
open-access spectrometers at Universities running experi-
ments on one or more of 1H, 13C, 31P and 19F. 31P NMR in
particular is useful in lipidomics as it can be used for all phos-
pholipids. Part of the reason for this is that all molecules that
do not contain phosphorus are in effect invisible. A tailor-
made solvent mixture that maximizes solubility of phospho-
lipids and gives good separation of resonances whilst limiting
that of polar and non-polar material (such as sugars and tri-
glycerides, respectively), has been developed for this purpose
[18–21]. The availability of such a solvent system has led to
31P NMR being used as the sole technique for acquiring
lipidomics data for some low- andmedium-throughput studies
[22–25].
31P NMR is useful for providing a straightforward spec-
trum of lipid class abundance but can also be used to acquire
data about the molecular structure of lipids and allows us to
correct for different ionization efficiencies in in MS
lipidomics data. These principles are the foundation of the
combination of NMR and MS for lipidomics known as dual
spectroscopy [13]. It can also be used to acquire all the
lipidomics data required for studies in which only molar con-
centration is required, e.g. structural studies [25]. However,
many of the lipidomics-specific aspects of 31P NMR have not
yet been described in detail and the technique is typically alien
to users not already familiar with NMR. This has made the
employment of 31P NMR in routine lipidomics difficult or
impossible for most labs.
This barrier to the use of 31P NMR as a technique for
lipidomics led us to develop a dedicated pipeline for it. We
have tested the limits of this technique and designed an ap-
proach for practical application of this method either indepen-
dently or as part of a larger lipidomics programme. The pur-
pose of this is to facilitate lipidomics across a range of fields in
biology in which lipidomics is being used. The outline of this
pipeline is shown in Fig. 1.
The limitations of the technique and the tools developed
were tested using a variety of samples. Lecithin from Glycine
max was used to establish the relationship between sample
size/mass and signal strength—valuable for determining min-
imum sample volumes and/or numbers of acquisition scans. A
variety of mouse tissues were also used to identify a full range
of phospholipids and their shifts. Lecithin was also used to
explore the relationship between sample age and lipid profile,
several resonances (through adducts) and stretching.
This pipeline is important as it facilitates the use of another
technique for lipidomics and increases that technique’s appli-
cability. It also adds to the increasing use of phosphorus31P
NMR in metabolomics [26]. The increasing desire and reli-
ance upon lipidomics and metabolomics data for answering
biological questions creates a demand for a choice of finely-
drawnmethods, not only for a straightforward answer as to the
composition of a system but also approaches for verification
and validation of data to increase confidence in the omics data
acquired. The present pipeline is designed to be flexible and
offer approaches to all these needs.
Methods
Materials, consumables and chemicals Solvents, reagents, fine
chemicals and NMR tubes were purchased from
SigmaAldrich (Gillingham, Dorset, UK). Lecithin lipid mix-
ture was purchased from Holland and Barrett in 2020 and not
purified further.
Animal model All biological samples were isolated from ex-
perimental mice used under ethically-approved studies. All
procedures were conducted in accordance with the UK
Home Office Animal (Scientific Procedures) Act 1986 and
local ethics committees at either Aston University, King’s
College London and the Universities of Nottingham and
Cambridge, as described previously [17, 27–29].
Solvent system for solution phase NMR Samples were dis-
solved in freshly-made stock solutions of a modified [13,
22] form of the ‘CUBO’ solvent system [18–21] in which
the amount of dueteriated dimethylformamide d7-DMF was
minimized. Stocks comprised dimethylformamide (3·5 mL),
d7-DMF (1·5 mL), triethylamine (1·5 mL) and guanidinium
chloride (500 mg) or multiples thereof.
Tissue sample preparation Fibrous animal tissue samples
were prepared and extracted as described recently [13, 30].
Briefly, the tissue of interest was homogenized with a hand-
held homogenizer in GCTU to give an homogenous,
pipettable solution with at least 1 μL lipid/60 μL homogenate
that was stored at −80 °C until extraction.
Lipid extraction and sample preparation for 31P NMR
Appropriate tissue homogenates were combined to give 5–
10 mg of phospholipid per NMR sample. The extraction
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was as described previously [13, 15]. Briefly, pooled homog-
enates (5–8 mL) were diluted (stock solution of DMT, 50 mL,
Falcon tube) and agitated before centrifugation (3·2 k × g, 2
min). The aqueous fraction and the mesophasic solid were
discarded, and the organic solution dried under a flow of ni-
trogen. The resulting lipid films were dispersed in CUBO
immediately (700 μL) and transferred (~650 μL) to a
Wilmad® 507PP tube and queued for data acquisition within
72 h.
NMR spectrometer and probe (1D). Lipid samples were run
on a Bruker Avance Neo 800 MHz spectrometer, equipped
with a QCI cryoprobe probe. 1D Phosphorous experiments
were acquired using inverse gated proton decoupling.
Spectra were averaged over 1312 transients with 3882 com-
plex points with a spectral width of 14·98 ppm. An overall
recovery delay of 8·4 s was used. Data were processed using
an exponential line broadening window function of 1.5 Hz
prior to zero filling to 32,768 points and Fourier transform.
Subsequent integrations above a noise threshold of 0·01% of
the total 31P were used to establish a given phosphorus envi-
ronment’s molar quantity.
NMR spectrometer and probe (2D). 31P-HSQC spectra were
acquired using an XY16-CPMG sequence for transfer and
GARP-4 decoupling. The direct dimension consisted of
3072 points with 16 transients, and 2048 points in t1 collected
using non-uniform sampling with a 25% sparsity, giving 512
points overall for the indirect dimension. Data were processed
with compressed sensing, linear prediction in F1 and a shifted
sine squared window functions.
Data processing and statistical methods. NMR data were
processed and deconvoluted using TopSpin 4.0.7. Signal-to-
noise ratios were calculated using NMRProcFlow 1.3 online.
Univariate and bivariate statistical calculations were made
using Microsoft Excel 2016. Graphs were prepared in Excel
2016.
Results & discussion
A pipeline for describing the use of 31P NMR in lipidomics
requires a detailed investigation of several steps (Fig. 1).
However some of these may not be obvious. Before data are
acquired, the sample must be dissolved, remain stable, be
concentrated enough and the pulse sequence used by the in-
strument must be appropriate for the hypothesis being tested
(e.g. suitable for quantitative measurements). Once data are
collected, identification of resonances by shift and couplings
is required. All the relevant steps are described in order below.
Solvent system
The desire to acquire lipidomics data using 31P NMR has led
to the development of solution phase solvent systems for the
purpose. Several solvent systems have been tested, including
detergent-based systems [31–33] and chloroform-methanol
mixtures [34–37]. However, high viscosity and difficulty in
recovering the sample (detergent systems), and relatively low
solubility of lipids (chlorinated solvents) have limited the use
of these particular solvent systems in detailed lipidomics stud-
ies involving batches of samples. Furthermore, both of these
solvent systems can dissolve phosphorus-containing com-
pounds that are not lipids, adding to the number of signals
observed thus adding noise.
These limits led to the development of a solvent system
tailored for 31P NMR lipidomics, originally described as the
‘CUBO’ mixture [19]. It is more effective than other systems
due to its ability to dissolve larger sample masses, specificity
Fig. 1 The sequence of steps required in acquiring a lipidome. Tissues
from biological samples appropriate to the study (1) are isolated and
homogenized as appropriate for extraction (2) and sample prepared and
run (3). Data acquisition and processing (4) yields the lipidome (5). The
present study codifies the requirements of steps going from sample prep-
aration to data analysis as a pipeline
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for phosphorus-containing lipids, with improved resolution
and lower viscosity. The sample can also be recovered with
relative ease. Several tests of CUBO against chloroform-
methanol mixtures have confirmed this [18–20], with compar-
isons between spectra from samples with detergent-based sol-
vent systems and CUBO showing better resolution in the lat-
ter. The CUBO system has been developed further by us to
include a source of deuterium (d7-DMF) that allows such
samples to be locked during preparation for data acquisition,
and thus be run more easily [38]. Around 20% d7-DMF is
typically enough for locking in experiments on open-access
instruments. The modified CUBO solvent system has a re-
markable tolerance to the amount of lipid in the sample,
around 1·5 orders of magnitude from the minimum detectable.
Samples can be prepared simply (see Methods) by dissolving
lipid films in the solvent and decanting to the glass tubes.
Sample concentration
The amount of sample available is often limited in metabolomics
studies, especially in human trials. It is therefore essential to
know the minimum mass of the mixture of phospholipids re-
quired to produce a viable 31P NMR sample and how samples
of different concentrations compare. The concentration of
analytes in a given biological sample may be quite different to
others and so assessment of the phospholipid concentration in a
sample type of interest is useful before collection of the samples
for a study. We tested the quality of spectra against the mass of
lipid per sample. Phospholipid (lecithin) extracted from Glycine
maxwas used to explore this as it was a lipidmixture available in
quantity that comprised a variety of commonplace lipids. A con-
centration scan of lecithin (1·0–32·0 mg/650 μL, Fig. 2, data
acquired 48 h after sample preparation) showed that the shift of
some resonances is concentration-dependent with respect to
phosphatidylcholine (referenced to 0·00 ppm, with other signals
assigned as per previous reports [13, 18–22, 38]).
Phosphatidylethanolamine (PE, 0·60–0·50 ppm) shifted
downfield with increasing concentration, where phosphatidic
acid (PA, 5·32–5·25 ppm) and lyso-phosphatidic acid (LPA,
6·03–5·96 ppm) moved upfield through the scan. The more
u p f i e l d o f t h e t w o s i g n a l s a s s o c i a t e d w i t h
phosphatidylglycerol (PG, 1·24–1·21 ppm) moved downfield
with increasing concentration, appearing as one broad reso-
nance in the 32 mg sample. However, the shifts assigned as
lyso-phosphatidylcholine and phosphatidylinositol (LPC, PI)
were not concentration-dependent in this range.
This relationship between concentration and shift raised
questions about what threshold should be used for regarding
a lipid as ‘present’. Generally, in metabolomics and
lipidomics, a signal to noise (S/N) ratio of 3:1 is required for
a signal to be regarded as genuine. We therefore plotted the S/
N for resonances of samples in this concentration span to
characterize the relationship between concentration and signal
strength (see Supplementary Information (ESM) Fig. S1). The
width of the concentration scan of lecithin showed that the
minimum mass of phospholipid concentrate for an S/N of 3
is 1 mg/sample for resonances PA, PC, PE, PI and PS (ESM
Fig. S1, log(3) = 0·477). Samples of higher concentration
provide better resolution and of yet more signals, with LPA,
CL and PG showing a S/N of >3 from a sample size of 4 mg.
However, the S/N does not continue linearly above 16 mg for
one of the resonances assigned to PE. This suggests that the
concentration range of 4–16 mg is generally the optimum
range for mixed lipid samples in an 800 MHz field with 656
Fig. 2 Sample concentration scan. Samples comprised Lecithin extracts
from Glycine max, run 48-72 h after sample preparation. Samples pre-
pared in themodified CUBO solvent system, 650μL/sample (13, 22), run
at 293 K. y axis shows relative intensity (arbitrary units), x axis shows
chemical shift (ppm). σP (324 MHz, CUBO, ppm) 6·1–5·9, lyso-phos-
phatidic acid; 5·4–5·2, phosphatidic acid; 1·65–1·55, lyso-
phosphatidylinositol; 1·28–1·20, phosphatidylglycerol; 1·15–0·95,
phosphatidylglycerol; 0·85–0·80, sphingomyelin; 0·60–0·57, phosphati-
dylethanolamine; 0·57–0·55, phosphatidylethanolamine; 0·55–0·51,
phosphatidylethanolamine; 0·50–0·48, phosphatidylethanolamine; 0·46–
0·43, lyso-phosphatidylcholine; 0·30–0·25, unk.; 0·19–0·16 unk.; 0·00,
phosphatidylcholine (calibration reference)
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scans. We therefore support the suggestion for pooling sam-
ples for each phenotype in human trials [13] to compare these
groups using 31P NMR. These results suggest that a minimum
of 4 mg of lipids from biological extracts is required for a
reliable 31P NMR sample of typical mixed lipids. Although
this may be challenging for some human studies, this sample
size is more achievable, even desirable, for small-scale studies
[23, 25].
Technical variation
Biological systems are inherently complicated and thus sever-
al measurements are typically made in order to establish the
distribution of values that represent individual properties.
Thus, the convention for six or more experimental measure-
ments (true measures) also applies to phospholipidomics stud-
ies. However, technical replicates (repeated measurements of
the same sample) in modern NMR are not required. NMR
instruments are calibrated through regular QC runs to check
shimming, locking etc. At the beginning of a sample run the
system is locked to calibrate the chemical shift and shimmed
to a specification. 90 degree pulses are calibrated every day
and sometimes more frequently to ensure radio frequency
(RF) performance and the RF circuits are tuned and matched
for each sample. Environmental conditions, such as tempera-
ture, are also controlled and faults reported. This fixes the
“baseline” so each sample is starting from the same point.
Faults with drifting RF would result in very noticeable effects,
RF is in megahertz (MHz) we detect Hz so small errors would
cause very large changes, this is an example of real time
checking. Additionally, each NMR experiment is a stand-
alone experiment in which we signal average over >1000
experiments. These factors mean that conventions in biologi-
cal studies for repeated experimental measurements are re-
quired, but repeated measurements of the same sample are
not. Details of how samples change with age is described next.
Sample age/storage
The shelf-life of samples after preparation for data acquisition
is of interest as it dictates the size of analytical batches and the
timing of data collection. Several aspects of the sample for-
mat, such as the relationship between the analytes and the
solvent, affect both sample preparation procedures and sample
shelf-life. Lipids have several known chemical sensitivities,
including to chloroform and bases [13, 39]. We therefore
sought to characterize the relationship between sample age
and the lipid profile observed in order to determine the opti-
mum range and consequences for the sample outside of this.
The first test was to run the same set of samples shown in
Fig. 2 after 21 days to identify any significant changes in lipid
profile (ESM Fig. S2). The results of this test showed little
gross change, though there is evidence for some minor
changes. In order to identify the changes that occur with age,
we constructed a time-scan of lecithin (Fig. 3). This comprised
four time points, the first of which was at just ~15 min of
exposure to the solvent. The results showed a time-
dependent change in the chemical shift of PA, PE and PI but
no change in integration and was reflected in the ageing of
samples of lipids extracted from tissues, such as mouse brain
(ESM Fig. S3). One effect evident in this scan was an increase
in the size of the LPC signal with respect to PC (referenced to
the same integration and shift, 0·00 ppm). This was investi-
gated next.
The increase in abundance of LPC with sample age was
consistent with at least one anecdotal observation [17] and led
us to the hypothesis that base-mediated hydrolysis of ester
bonds occurred, presumably driven by triethylamine. It is use-
ful to test this hypothesis because changes to the lipid profile
with age are relevant for interpretation of data and consistent
sample handling. The relationship between PC and LPC at 48
h and at 21d over the sample concentration range of 1–32 mg
showed that the ratio of LPC to PC was 50–60% higher at 21d
than at 48 h across the concentration range tested (ESM Fig.
S4). This suggests that hydrolysis of PC increases with sample
age but not concentration and is tolerable in the optimum
range for S/N of 4–16 mg. This leads us to suggest that in
addition to a mass of 4–16 mg for typical mixed samples, data
acquisition within one week will provide reliable data without
significant hydrolysis.
Pulse sequence
The CUBO solvent mixture is designed to facilitate sample
preparation with a high concentration of lipids in a mono-
disperse format and relatively low viscosity, minimizing T1
and T2. T1 is field-dependent, with values ranging from 8·4 s
(800 MHz, 700 MHz) [23] to 6·5 s (400 MHz) [22].
For 1D NMR experiments, it is important to acquire the
spectrum under quantitative conditions. Specific attention is
needed for the decoupling methods. Inverse gated decoupling
is needed to avoid NOE transfer. Additionally, sufficient re-
laxation time (T1) is required to give full recovery. In all our
experiments, we used the WALTZ-16 decoupling with a re-
laxation delay of 5 × T1.
2D 31P-1H correlation experiments were run using an
HSQCmethod. On cooled probes, good results were achieved
with the XY16-CPMG sequence. XY16-CPMG is a low-
power composite 180° pulse train that was applied to both
1H and 31P nuclei during the evolution of long-range cou-
plings as a way to eliminate phase distortions caused by ho-
monuclear proton-proton couplings that evolve at the same
time. The indirect 31P dimension suffers from low chemical
shift dispersion. This problem can be compensated for by
running a higher number of points in the indirect dimension
(t1). The upper limit of the number of points is limited by the
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relaxation time of 31P (T2). We found 2048 points was a good
compromise. To reduce acquisition times to reasonable
lengths, non-uniform sampling methods can be deployed.
The resolution allowed real-world discrimination of 31P sig-
nals that are separated by as little as 0·025 ppm (5·6 Hz, 324
MHz 31P).
Signal identification: Resonances
A critical step in interpreting metabolomics data is assigning
the signals acquired to the appropriate molecular species. In
the context of 31P NMR for lipidomics, this means assigning
resonances to lipid head groups. Previous studies have already
analysed milk [21], lecithin [19] and seed extract [13] sam-
ples. However, several important tissue types that are desir-
able for lipidomics studies are not yet described, and it is not
clear whether it is possible to align acquisitions taken on dif-
ferent instruments decades apart. This led us to codify the
shifts for as many naturally-occurring lipid classes as possible
in a range of tissues in one analytical batch on one instrument.
One dimensional 31P NMR spectra were collected for lipids
extracted from liver, heart and brain (Mus musculus) and lec-
ithin (Glycine max). Spectra showed that the lecithin
contained phospholipids that comprised diglyceride moieties
but not ether-glycerides or sphingosines, agreeing with previ-
ous reports [40]. The lipids appear in different proportions
across samples, clarifying signals associated with mid-sized
and minor peaks (Fig. 4). A list of resonances is shown in
ESM Table S1. Our approach also represents an advance in
assigning signals as it allows us to understand how individual
lipids behave in different mixtures as well as by concentration.
However, ambiguities remain. Particularly difficult is the busy
region 0·45–0·60 ppm in which there are known to be signals
for PE-plasmalogen, PE (×2), PS and LPC [13, 18–21, 38].
This led us to use 2D spectra to assign the signals in these
samples.
We used 2D NMR (1H/31P HSQC) to determine P-H cou-
plings and assign resonances and thus identify head groups.
Three biological samples, mouse brain (Fig. 5), mouse liver
(Fig. 6) and soya lecithin (Fig. 7) were used. HSQC spectra of
the brain extract showed four strong correlations of the phos-
phorus atom associated with phosphatidylcholine with proton
environments and four much weaker ones that form two pairs
(σP, 0·00 ppm, Fig. 5). Using the known molecular structure
of this phospholipid (inset, Fig. 5), the stronger signals were
assigned to the two methylenes of the choline head group, the
sn-3methylene and sn-2methine of the glyceryl moiety. A 2D
spectrum of mouse plasma that consists chiefly of LPC and
PC informed this assignment. These two lipids have known
referenced 1D shifts of ~0·48 and 0·00 ppm, respectively
(ESM Fig. S5). LPC does not have a resonance at σH 5·2
ppm and the resonance at 4·0 ppm appears slightly upfield at
3·9 ppm. The signal at σH 5·2 ppm is characteristic of the
methine proton in a glyceryl moiety of a glyceride [41], and
thus its disappearance with a slight shift upfield of the
neighbouring signal for the methylene associated with the
sn-3 position are consistent with a fatty acid residue being
removed from the sn-2 OH in the glyceryl moiety.
The resonances in the 0·60–0·45 ppm region include im-
portant phospholipids such as PE and PS and for most mam-
malian and other samples it is important to be able to assign
these unambiguously. Mouse brain and liver and soya lecithin
samples are ideal for this as they comprise the appropriate
lipids in sufficient abundance to show clear resonances but
Fig. 3 Sample age scan. Samples comprised Lecithin from Glycine max,
run 15min, 48 h, 21d and 52d after sample preparation. Samples prepared
in the modified CUBO solvent system, 650 μL/sample (13, 22), run and
stored at 293 K out of direct sunlight. σP (324 MHz, CUBO, ppm) 6·1–
5·9, lyso-phosphatidic acid; 5·4–5·2, phosphatidic acid; 1·65–1·55, lyso-
phosphatidylinositol; 1·28–1·20, phosphatidylglycerol; 1·15–0·95,
phosphatidylglycerol; 0·85–0·80, sphingomyelin; 0·60–0·57, phosphati-
dylethanolamine; 0·57–0·55, phosphatidylethanolamine; 0·55–0·51,
phosphatidylethanolamine; 0·50–0·48, phosphatidylethanolamine; 0·46–
0·43, lyso-phosphatidylcholine; 0·30–0·25, unk.; 0·19–0·16 unk.; 0·00,
phosphatidylcholine (calibration reference)
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those abundances also di f fer f rom one another .
Magnifications of this region of the 2D brain spectrum
showed two pairs of signals, one pair coupling with additional
signals at 3·2 ppm in the proton spectrum (Fig. 5). This is
consistent with previous reports that suggested and even
showed that interaction of the PE head group with the solvent
system results in several signals [21–23, 38]. The signals ob-
served in this 2D spectrum (Fig. 5) deepen our understanding
Fig. 4 Sample type plot. Samples comprised lipid extracts from either
Lecithin extract from Glycine max or heart, liver or brain tissues from
Mus musculus. Samples were prepared in the modified CUBO solvent
system, 650 μL/sample (13, 22), and run at 293 K and within 48 h of
sample preparation. σP (324 MHz, CUBO, ppm) 6·1–5·9, lyso-phospha-
t id ic ac id ; 5 ·4–5·2 , phosphat id ic acid; 1 ·65–1·55, lyso-
phosphatidylinositol; 1·28–1·20, phosphatidylglycerol; 1·15–0·95,
phosphatidylglycerol; 0·85–0·80, sphingomyelin; 0·60–0·57, phosphati-
dylethanolamine; 0·57–0·55, phosphatidylethanolamine; 0·55–0·51,
phosphatidylethanolamine; 0·50–0·48, phosphatidylethanolamine; 0·46–
0·43, lyso-phosphatidylcholine; 0·30–0·25, unk.; 0·19–0.16 unk.; 0.00,
phosphatidylcholine (calibration reference)
Fig. 5 31P-HSQC spectrum of lipids extracted from brain of Mus
musculus showing coupling between P and H nuclei in the phosphate
diester, and glyceryl and choline/ethanolamine moieties. Resonances that
cannot be reconciled are demarked with number is parentheses (1–3).
Resonances that concurred with previous assignments (18–21, 39) are
labelled. Inset molecular structure is of the head group of phosphatidyl-
ethanolamine with proton environments marked and colour-coded with
the spectrum (a-d). σH (800 MHz, CUBO) ~5·2 ppm (a, red), (RO)CH2-
(RO)CH-CH2-O-P; ~4·4 ppm, CH2-O-P(O)(O
−)-O-CH2CH2N(CH3)3
(PC/LPC); ~4·0 ppm (b, green), (RO)CH2-(RO)CH-CH2-O-P; ~3·9
ppm, CH2-O-P(O)(O-)-O-CH2CH2N(CH3)3 (PC/LPC); ~3·85 ppm (c,
beige), CH2-O-P(O)(O-)-O-CH2CH2NH3
+; ~3·2 ppm (d, blue) CH2-O-
P(O)(O−)-O-CH2CH2NH3
+ (PE). LPC, lyso-phosphatidylcholine; PC,
phosphatidylcholine; PE, phosphatidylethanolamine
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of this phenomenon as they provide a possible explanation for
the presence of several signals through different conformers.
For example, if the primary amine in PE is protonated, it is
favourable for it to form attractive electrostatic interactions
with the anionic phosphate group. However, if it is
deprotonated, the lone pairs are exposed and there will be a
repulsion between the amine and phosphate. The exposed
primary amine and phosphate may therefore interact with
Fig. 6 31P-HSQC spectrum of lipids extracted from liver of Mus
musculus showing coupling between P and H nuclei in the phosphate
diester, and glyceryl and choline/ethanolamine moieties. Resonances that
cannot be reconciled are marked with number is parentheses (1, 3;
numbering is consistent with Fig. 5). Resonances that concurred with
previous assignments (18–21, 39) are labelled. CL, cardiolipin; LPC,
lyso-phosphatidylcholine; PC, phosphatidylcholine; PE, phosphatidyl-
ethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; SM,
sphingomyelin
Fig. 7 31P-HSQC spectrum of lipids extracted from Glycine max (soya
lecithin) showing coupling between P and H nuclei in the phosphate
diester, and glyceryl and choline/ethanolamine moieties. Resonances that
cannot be reconciled are marked with number is parentheses (1, 2, 4, 5;
numbering consistent with Figs. 5 and 6). Resonances that concurred with
previous assignments (18–21, 39) are labelled. The red box shows the
resonances for the protons nearest the P atom in PI, (RO)CH2-(RO)CH-
CH2-O-P(O)(O-)-O-CHR2. CL, cardiolipin; LPC, lyso-phosphatidylcho-
line; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG,
phosphatidylglycerol; PI, phosphatidylinositol; SM, sphingomyelin
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electropositive systems such as triethylammonium or
guanidinium ions, or metal ions such as that of sodium. This
complicated set of possibilities led us to investigate the phe-
nomenon of adducts in these samples, i.e. electrostatic inter-
actions between the lipids and the solvent system.
Signal identification: Adducts
An advantage of 31P NMR over mass spectrometry is that
analytes do not need to be ionized to be detected. However,
ionic compounds such as those containing a phosphate inter-
act with local ions through electrostatic attraction. This chang-
es how the 31P nucleus is deshielded and thus alters the chem-
ical shift its resonance(s) adopt. The interaction of analytes
with the solvent system is understood to be the reason that
more than one resonance is observed for lipids such as PE.
To simplify the job of assigning the signals from 31P NMR
data, an extraction that minimizes the range of adducts is sug-
gested, e.g. favouring triethylammonium [13, 15]. The latter
adduct is entirely compatible with the CUBO solvent system
and generally offers better solvation in organic solvents.
However, some sodiated, potassiated or ammoniated analytes
may also be present depending upon sample handling. The
presence of guanidinium ions also offers scope for electrostat-
ic interaction.
We tested the hypothesis that some signals could be as-
cribed to sodiated lipid adducts by adding sodium chloride
(10 mg) to the sample solution preparation tube, before
Fig. 8 Sample adduct plot. Panel A, samples comprised lipid extracts
from Glycine max that were made as normal or exposed to NaCl (10
mg) or triethylammonium chloride (10 mg) after being made; B, samples
comprised lipid extracts from Glycine max that were made as normal or
exposed to guanidinium chloride (10–50 mg) was added to aliquots of a
sample stock (10 mg lecithin, 650 μL solvent per sample). Samples were
prepared in the modified CUBO solvent system with a final volume of
650 μL/sample (13, 22), and run at 293 K and within 72 h of sample
preparation. σP (324MHz, CUBO, ppm) 6·1–5·9, lyso-phosphatidic acid;
5·4–5·2, phosphatidic acid; 1·65–1·55, lyso-phosphatidylinositol; 1·28–
1·20, phosphatidylglycerol; 1·15–0·95, phosphatidylinositol; 0·85–0·80,
sphingomyelin; 0·60–0·57, phosphatidylethanolamine; 0·57–0·55, phos-
phatidylethanolamine; 0·55–0·51, phosphatidylethanolamine; 0·50–0·48,
phosphatidylethanolamine; 0·46–0·43, lyso-phosphatidylcholine; 0·30–
0·25, unk.; 0·19–0·16 unk.; 0·00, phosphatidylcholine (calibration
reference)
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decanting into the glass sample tube. The same test for
triethylammonium and guanidinium adducts was done by
adding triethylammonium chloride (1 sample, +10 mg) and
a range of masses of guanidinium chloride (5 samples, 10–50
mg/sample) respectively. The results of this test showed that
the presence of signals for LPA, PA, PI and PE all differ
relative to PC for both triethylammonium and sodium ions
(Fig. 8A). A scan of guanidinium concentration showed that
this adduct also modulated the shift of several lipids, but not
always in the same direction as either triethylammonium or
sodium (Fig. 8B). This showed that interaction with ions is
essential, but also suggests that the interaction with the solvent
and local ions is not straightforward. It underscores the need
for consistent handling within and between analytical batches.
Our recommendations for minimizing variation between sam-
ples are therefore for extractions to be carried out in parallel
using the same procedure with solvents and handling proce-
dures carried out to minimize the addition of adducts other
than TEAC and guanidinium. This will also facilitate assign-
ment of resonances.
Quantification: Signal deconvolution
The solvent system used in the present study offers the best
separation and resolution of signals of the three types of sol-
vent system currently reported (CUBO, chloroform/methanol,
aqueous detergent), however, some signals remain relatively
close to others and thus a clearer approach is needed before the
area of the resonance can be measured and thus the relative
molar concentration determined. As discussed above, reso-
nances for PE-plas, PS, LPC and two for PE appear 0·60–0·
45 ppm. A useful method for quantification (allied to signal
identification, vide supra) is to use the deconvolute (dcon)
function in Bruker’s TopSpin software. This assigns a known
lineshape to peak-picked resonances, which facilitates quanti-
fication for all signals in the spectrum. An appropriate
lineshape (Gaussian, Lorenzian or a compromise between
them) allows resonances to be integrated and thus the abun-
dance of that head group to be determined. A list of integra-
tions can then be created (%mol of the total) and exported to a
spreadsheet workbook.
Conclusion
In this paper we have described a pipeline for using 31P NMR
for lipidomics. This makes the technique more accessible for
hypothesis-driven research and new users. Several existing
questions about the use of this technique for profiling the lipid
composition of biological samples have been answered, in-
cluding which resonances represent what lipids, how concen-
tration and ageing affect samples and how much material is
required for a useful spectrum. This provides all of the tools
necessary for both new and experienced NMR spectroscopists
to use this technique to answer scientific questions that require
lipidomics data. It also dovetails neatly with lipidomics data
collected by mass spectrometry for dual spectroscopy.
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